Dementia and Alzheimer's

Few diagnoses are feared as deeply as dementia. It reaches past the body and into the things we think of as ourselves — memory, language, judgement, the thread of a life held together in the mind. And yet it is widely misunderstood: confused with ordinary forgetting, mistaken for an inevitable part of growing old, and spoken about in a fog of dread that makes it harder, not easier, to face. This page is an attempt to clear some of that fog. It sets out what dementia actually is, the different diseases that cause it, why it happens and what raises the risk, how it is recognised and diagnosed, what can be done, and — just as importantly — how to live with it and care well for someone who has it. It is written for anyone touched by it: a person newly worried about their own memory, a family trying to understand a diagnosis, a carer, or simply someone who wants to know.

What dementia actually is

The first thing to understand is that dementia is not a single disease. It is a syndrome — a recognisable pattern of symptoms — caused by damage to brain cells. The pattern is a progressive decline in mental abilities serious enough to interfere with everyday life: not just memory, but thinking, language, orientation, judgement, problem-solving, and often mood and behaviour too. Several different diseases can produce it, much as “arthritis” names a pattern of joint trouble that several conditions can cause.

The brain runs on roughly eighty-six billion neurons, each connected to thousands of others, passing signals across tiny gaps. In dementia these cells are progressively damaged and die, and the connections between them are lost. As particular regions degenerate, the functions they supported falter: when the hippocampus — the brain's filing clerk for new memories — is hit early, as in Alzheimer's, the first sign is often difficulty laying down recent memories while older ones stay intact.

The second thing to understand is that dementia is not a normal part of ageing. It is common in older people, and age is by far the biggest risk factor, but plenty of people live into their nineties with their minds sharp. Some slowing is normal with age — names take a moment longer to surface, a train of thought is more easily lost. Dementia is a disease process on top of that, not the ordinary wear of the years.

So how do you tell ordinary forgetfulness from something more? It is rarely a single moment so much as a direction of travel. Forgetting where you put the keys is ordinary; forgetting what the keys are for is not. Losing the thread of a conversation happens to everyone; repeatedly asking the same question within minutes, getting lost in familiar places, or struggling with a once-routine task like managing money points further. The hallmark of dementia is that the difficulties worsen over time and begin to intrude on daily life.

Between normal ageing and dementia lies a recognised middle ground: mild cognitive impairment (MCI). Here memory or thinking is measurably weaker than expected for someone's age, but not yet enough to derail everyday independence. MCI sometimes — not always — progresses to dementia, and sometimes stays stable or even improves, especially when a treatable cause like depression, poor sleep, thyroid trouble or medication side-effects turns out to be behind it.

The types of dementia

Because several diseases produce the syndrome, “dementia” is best thought of as an umbrella. The major causes overlap in their later stages but differ in what goes wrong, where in the brain, and what the earliest signs are. Knowing the type matters: it shapes what to expect, and which treatments might help or harm.

• Alzheimer's disease is the most common cause, behind roughly two-thirds of cases. It is marked by amyloid plaques and tau tangles, usually begins in the memory centres, and progresses gradually over years.
• Vascular dementia comes from damage to the brain's blood supply — a stroke, or many small “silent” ones that starve patches of brain of oxygen. It can advance in a stepwise way, with noticeable drops after each event, and often involves slowed thinking and problems with planning more than early memory loss.
• Dementia with Lewy bodies is caused by tiny protein deposits (Lewy bodies, made of alpha-synuclein) in nerve cells. It brings fluctuating alertness, vivid visual hallucinations, movement problems like those of Parkinson's, and a striking sensitivity to certain antipsychotic drugs — one reason getting the type right is so important.
• Frontotemporal dementia (FTD) damages the frontal and temporal lobes. It often strikes younger — in the fifties and sixties — and tends to change personality, behaviour and language first, rather than memory, which can make it hard to recognise at first.
• Mixed dementia — most often Alzheimer's together with vascular damage — is very common, especially in older people, where post-mortem studies show more than one process at work in the same brain.

Shares are approximate and overlap, because mixed pathology is so common; the figures vary between studies and rise with age.

Causes and risk factors

Why does the brain start to break down? The honest answer is that, for the common dementias, the full chain of cause is still not settled — we can see the plaques, tangles and vascular damage, but exactly why they begin, and in what order they drive harm, remains an area of active research. What we can speak about confidently is risk: the factors that make dementia more or less likely.

Age is the single biggest one. The risk roughly doubles every five years or so after sixty-five. This is not because ageing causes dementia directly, but because the underlying disease processes have had more time to accumulate and the brain has less reserve to absorb the damage.

Genetics plays a part, though for most people a smaller one than feared. A handful of rare gene mutations cause early-onset Alzheimer's that runs strongly in families, but these account for a tiny fraction of cases. Far more common is the APOE-e4 gene variant, which raises Alzheimer's risk — carrying one or two copies makes the disease more likely and earlier, but plenty of carriers never develop it and plenty of non-carriers do. It shifts the odds; it does not seal a fate.

The most hopeful part of the picture is that a large share of risk is modifiable. The Lancet Commission on dementia prevention has identified a list of risk factors that, addressed across a lifetime, could prevent or delay a meaningful fraction of cases. They include:

• Less education in early life (less “cognitive reserve”)
• Hearing loss in mid-life — one of the largest single factors
• Untreated vision loss
• High blood pressure
• Smoking
• Obesity and type 2 diabetes
• Physical inactivity
• Depression
• Social isolation
• Excessive alcohol
• Traumatic head injury
• Air pollution

A word of caution against over-promising: these are associations and estimates, not certainties, and you can do everything “right” and still develop dementia, or nothing and never get it. The point is not to assign blame but to identify levers worth pulling.

Symptoms and stages

Dementia progresses, usually slowly, over years. Every person's path is different, and the type of dementia changes the order in which abilities are affected. Still, it helps to think in three broad stages — early, middle and late — while remembering that the boundaries are blurred and no two people move through them identically.

Early stage. The signs are subtle and easy to put down to stress or age. Recent memory slips — repeating questions, misplacing things, forgetting appointments. Familiar words go missing mid-sentence. People may lose track of dates or get muddled in unfamiliar places. Judgement and planning can falter — managing money or following a recipe becomes harder. Mood often shifts too: withdrawal, anxiety, low mood, irritability. Many people are aware something is wrong and find this stage frightening.

Middle stage. Difficulties become harder to hide and independence erodes. Memory gaps widen to include parts of one's own history; people may not recognise friends or, later, family. Confusion about time and place deepens, and people may wander or become disorientated even at home. Language grows more difficult. Help is increasingly needed with everyday tasks — dressing, washing, eating. Behaviour and mood can change markedly: agitation, suspicion, repetitive actions, disturbed sleep, sometimes hallucinations. This is often the most demanding stage for carers.

Late stage. The person needs full-time care. Memory loss is profound, communication may shrink to a few words or none, and the person becomes physically frail — difficulty walking, then swallowing, and growing vulnerability to infections such as pneumonia, which is a common cause of death. Through all of this, the capacity for feeling — comfort from a familiar voice, a held hand, music — often endures when much else has gone, and that matters enormously for how care is given.

How it is diagnosed

There is no single test that says “dementia”. Diagnosis is a process of building a picture and ruling things out, usually starting with a GP and often moving to a memory clinic or specialist.

• History. The most valuable information often comes from family or close friends, who can describe how abilities have changed over time — something the person themselves may not fully see. When the trouble began, how it has progressed, and how it affects daily life all matter.
• Cognitive tests. Short, structured assessments measure memory, attention, language and reasoning. Common ones include the MMSE (Mini-Mental State Examination) and the MoCA (Montreal Cognitive Assessment). They are screening tools, not verdicts — a score guides, but does not by itself diagnose.
• Blood tests. These help rule out other, sometimes reversible, causes of confusion: thyroid problems, vitamin B12 deficiency, infection, and so on. It is important not to mistake a treatable problem — including depression, which can mimic dementia — for an irreversible one.
• Brain scans. CT or MRI scans can show shrinkage, strokes or small-vessel damage and help distinguish types; specialised scans (such as PET) can sometimes detect amyloid or assess function.
• Emerging blood biomarkers. A major recent advance is the development of blood tests that detect markers of Alzheimer's biology, such as forms of tau and amyloid. These promise earlier, cheaper, less invasive diagnosis and are moving from research into clinics — one of the most important shifts in the field.

A clear diagnosis, though hard to receive, is worth having. It explains what is happening, rules out treatable mimics, opens access to treatment and support, and gives the person time to plan while they can still take part in decisions about their own future.

A short history

For most of history, the failing memory of the old was simply called senility — treated as the unavoidable softening of an ageing mind rather than disease. The turn came in 1906, when the German psychiatrist Alois Alzheimer described a patient named Auguste Deter. She had come to him in her early fifties with profound memory loss, confusion and paranoia — far too young for “senility” as it was then understood. After her death, examining her brain under the microscope, Alzheimer found the abnormal deposits and tangles of fibres that now bear his name. He had connected a clinical picture to a physical disease in the brain.

Over the twentieth century, that insight slowly displaced the old idea of senility. Researchers came to recognise that the changes Alzheimer described in his young patient were the same as those in many far older people too — that this was a disease, not merely age. Understanding then advanced along two great threads. The cholinergic hypothesis of the 1970s and 80s noted that Alzheimer's brains were short of acetylcholine, a chemical messenger important for memory, and led directly to the first useful drugs. The amyloid hypothesis proposed that the build-up of amyloid protein is the initiating event that drives the disease — an idea that has shaped decades of research and the newest treatments, while also drawing sharp debate over how complete an explanation it really is.

Treatment and management

It is best to be honest at the outset: for most types of dementia there is no cure, and no treatment that reliably stops or reverses the underlying disease. That is a hard truth, but it is not the same as “nothing can be done” — a great deal can be done to ease symptoms, slow some forms, and protect quality of life.

Symptom-relieving medicines. For Alzheimer's and some other types, cholinesterase inhibitors — donepezil, rivastigmine and galantamine — boost the acetylcholine that the cholinergic hypothesis flagged, and can modestly help memory and thinking for a time. A different drug, memantine, acts on the glutamate system and is used in moderate-to-severe Alzheimer's, sometimes alongside the others. These do not halt the disease, but for some people they soften symptoms and steady things for a while.

The new anti-amyloid antibodies. The drugs lecanemab and donanemab represent the first treatments aimed at the underlying biology rather than just the symptoms: antibodies that clear amyloid from the brain, and that have been shown to slow the decline of early Alzheimer's. The honesty here is important. The benefit is modest — a slowing of decline, not a halt or reversal — and the drugs carry real risks, including a side-effect called ARIA (amyloid-related imaging abnormalities): brain swelling or small bleeds, usually picked up on scans, occasionally serious. They require infusions, careful monitoring, and confirmation of amyloid in the brain, and questions of cost and access are unresolved. They are a genuine milestone, and not a cure.

Treating the vascular side. Where blood-vessel damage is part of the picture, controlling blood pressure, diabetes and cholesterol, not smoking, and staying active can help limit further harm — the same measures that protect the heart.

But the heart of good dementia care is not pharmacological at all. It is care, routine and environment: a calm, familiar setting; consistent daily rhythms; clear cues and reminders; meaningful activity and company; and patient, person-centred support. Much of what looks like “difficult behaviour” is unmet need or distress, and addressing it kindly — rather than reaching first for sedating drugs, which can be harmful, especially certain antipsychotics in Lewy body dementia — is usually the better path.

Living with dementia and caring for someone

A diagnosis of dementia is not the end of a meaningful life. Especially in the early and middle stages, people can live well — enjoying relationships, interests and a sense of purpose — for a long time, with the right support. The guiding idea, now central to good practice, is person-centred care: seeing the whole person, their history, preferences and dignity, rather than reducing them to a diagnosis or a set of problems to be managed.

Practical things help. Familiar routines and surroundings reduce confusion and anxiety. Clear labels, calendars, and reminders support independence. Good light, low noise and a calm atmosphere matter more than they might seem. Activities that connect to a person's past — music especially, which often reaches people when words no longer do — can bring real joy and settle distress. Maintaining physical health, social contact and gentle activity is good for body and mind alike.

Supporting carers is part of caring for the person. Looking after someone with dementia is one of the hardest and most under-recognised jobs there is — often round the clock, emotionally exhausting, and grief-laden as the person changes. Carers need their own support: practical help and respite, information, someone to talk to, and permission to look after their own health. Organisations such as Dementia UK (whose Admiral Nurses specialise in this) and the Alzheimer's Society exist precisely to help.

Advance care planning is a gift a person can give while they are still able. Setting out wishes about future care and treatment, and arranging legal powers (such as lasting power of attorney) so that a trusted person can make decisions later, removes a great burden from families and keeps the person's own voice in their care for as long as possible. These are hard conversations to start, but far easier to have early than late.

Through all of it, the aim is dignity and quality of life: comfort, respect, connection and as much autonomy as possible, for as long as possible. The person is still there.

What the research says

Dementia research is moving faster now than at any time in its history, on several fronts at once.

• Disease-modifying drugs. The arrival of anti-amyloid antibodies has, for the first time, shown that targeting the biology can slow Alzheimer's — modestly, and with risks, but a proof of principle. The next wave includes anti-tau therapies aimed at the tangles inside cells, which track closely with where and how badly the brain degenerates, plus efforts to combine approaches.
• Early detection. Blood biomarkers for Alzheimer's are a quiet revolution: a simple blood test that flags the disease's biology could allow diagnosis years earlier, when treatment and prevention have the best chance, and without expensive scans or invasive procedures. Reliable, widely available versions are close.
• Prevention. Perhaps the most consequential frontier is the least glamorous: reducing risk across whole populations. If a large share of dementia is linked to modifiable factors, then better treatment of blood pressure and diabetes, hearing-aid use, more education, cleaner air, less smoking and more activity could push dementia later in life or prevent cases entirely. Encouragingly, age-adjusted dementia rates have actually fallen in some richer countries, which hints that this is already happening.

None of this is a cure, and good science means resisting hype. But the direction is genuinely hopeful: earlier detection, the first treatments that touch the disease itself, and a growing understanding that a real share of dementia may be preventable.

Where to get help & more info

If you are worried about dementia — your own or someone else's — please talk to a doctor. These organisations offer trustworthy information, practical guidance and support:

• NHS — Dementia — symptoms, diagnosis and what to do, for the UK.
• Alzheimer's Society — UK support, advice and a helpline for people with dementia and carers.
• Dementia UK — specialist Admiral Nurses and support for families.
• Alzheimer's Research UK — research-focused information and explainers.
• WHO dementia fact sheet — the global picture and key facts.
• Alzheimer's Association (US) — information, a 24/7 helpline and care resources.
• National Institute on Aging (US NIH) — evidence-based information on Alzheimer's and related dementias.
• CDC — US public-health information on brain health and dementia.

Some of the figures and details on this page — typical ranges, statistics and the biology — were compiled with the help of AI tools and may contain errors or be out of date. They are shared in good faith for general interest only, and are not medical advice. Nothing here is a substitute for a doctor or a qualified health professional; if you are worried about dementia, please seek professional help. Check claims against primary medical sources before relying on them.